We have found the following

Finding Lifecycle Growth Beyond Indication Expansion

Learn how an optimal indication sequence creates a cumulative effect that is greater than the sum of its parts, influencing risk, pricing flexibility, commercial efficiency, and long-term asset value.

Designing the Optimal Indication Sequence

Learn how an optimal indication sequence creates a cumulative effect that is greater than the sum of its parts, influencing risk, pricing flexibility, commercial efficiency, and long-term asset value.

Lifecycle Pathways: A Framework for Long-Term Asset Value

Introducing lifecycle pathways, their architecture and design, as well as their role in helping pharma teams build an early lifecycle strategy that maximizes long-term asset value.

Second Brand Strategy: Viability, Approaches, and Risks for Pharma

A second brand strategy is a powerful but often misunderstood late lifecycle tactic. Discover when a second brand is appropriate and approaches that strengthen rather than dilute performance.

A Hybrid Archetyping Approach for Late Lifecycle Planning

Market archetypes provide a structured way to simplify complexity without losing strategic nuance, however, for late lifecycle planning, not all pharma archetyping approaches are equally effective.

Loss of Exclusivity: Key Factors Shaping Local Market Dynamics

Success post-loss of exclusivity is heavily determined by your local strategies and planning. We take a look at the key factors shaping local market dynamics and why they matter to your strategy.

Breadth, Depth, Sustainability: A Framework for Rethinking Lifecycle Management

Introducing a lifecycle management framework to help pharmaceutical teams fully unlock value by exploring the breadth, depth, and sustainability of an asset.

Early Lifecycle Planning: Your Compass for Unlocking Asset Value

Developing a new pharmaceutical asset is not unlike the voyage of cargo ship: success depends on having a compass to guide you. In pharma, that compass is early lifecycle planning.

Six Strategy Decision Points for Effective Lifecycle Management

Maximize pharma asset value with our infographic: Six Strategic Decision Points for balanced Lifecycle Management success.

5 Best Practices In Late Lifecycle Management

Navigate brand challenges with tailored late lifecycle management. Explore 5 key practices for success as your portfolio evolves.